ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: Relocation Of NCI Offices Nearly Complete; Hungary’s Eckhardt UICC President elect

November 4, 1988

IOM To Advise Army On Spending $210 Mil. Breast Cancer Money

January 8, 1993

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

October 31, 2014

Medenica’s Privileges Extended; Patient sue Hilton Head Physicians

June 4, 1993

New Treatment Modalities For Endometrial Cancer

March 26, 2004